全文获取类型
收费全文 | 3401篇 |
免费 | 197篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 190篇 |
妇产科学 | 64篇 |
基础医学 | 384篇 |
口腔科学 | 69篇 |
临床医学 | 342篇 |
内科学 | 963篇 |
皮肤病学 | 94篇 |
神经病学 | 198篇 |
特种医学 | 416篇 |
外科学 | 288篇 |
综合类 | 54篇 |
预防医学 | 204篇 |
眼科学 | 72篇 |
药学 | 159篇 |
2篇 | |
中国医学 | 2篇 |
肿瘤学 | 166篇 |
出版年
2023年 | 8篇 |
2022年 | 27篇 |
2021年 | 47篇 |
2020年 | 32篇 |
2019年 | 53篇 |
2018年 | 78篇 |
2017年 | 47篇 |
2016年 | 52篇 |
2015年 | 71篇 |
2014年 | 87篇 |
2013年 | 103篇 |
2012年 | 115篇 |
2011年 | 105篇 |
2010年 | 142篇 |
2009年 | 111篇 |
2008年 | 106篇 |
2007年 | 158篇 |
2006年 | 120篇 |
2005年 | 129篇 |
2004年 | 96篇 |
2003年 | 94篇 |
2002年 | 94篇 |
2001年 | 84篇 |
2000年 | 87篇 |
1999年 | 87篇 |
1998年 | 141篇 |
1997年 | 165篇 |
1996年 | 141篇 |
1995年 | 120篇 |
1994年 | 125篇 |
1993年 | 103篇 |
1992年 | 51篇 |
1991年 | 57篇 |
1990年 | 52篇 |
1989年 | 71篇 |
1988年 | 68篇 |
1987年 | 55篇 |
1986年 | 64篇 |
1985年 | 59篇 |
1984年 | 39篇 |
1983年 | 22篇 |
1982年 | 27篇 |
1981年 | 33篇 |
1980年 | 28篇 |
1979年 | 10篇 |
1978年 | 10篇 |
1977年 | 27篇 |
1976年 | 30篇 |
1975年 | 22篇 |
1970年 | 6篇 |
排序方式: 共有3678条查询结果,搜索用时 15 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
3.
Preliminary data suggest that lactitol (beta-galactoside-sorbitol), a new synthetic non-absorbable disaccharide, has beneficial effects on chronic portal systemic encephalopathy. To compare the efficacy of lactitol vs. lactulose in the treatment of acute portal systemic encephalopathy (PSE), 40 cirrhotic patients with an acute episode of PSE were randomly allocated to one of two groups: group A (20 patients) received lactulose (30 ml/6 h) and group B (20 patients) lactitol (12 g/6 h). These doses were adjusted daily to obtain two bowel movements per day. The duration of treatment was 5 days. Age, sex, hepatic and renal function, precipitating factors and level of PSE measured by clinical examination, EEG and number connection test were similar in the two groups. A complete clinical resolution of PSE occurred in 11 patients in each group. In 5 patients of the lactulose group and in 6 of the lactitol group there was a moderate improvement of PSE during the study. Finally, 4 patients in the lactulose group and 3 in the lactitol group did not respond to treatment. No side effects attributable to therapy were observed in either group. These results indicate that lactitol is as effective as lactulose in the management of patients with cirrhosis and acute PSE. 相似文献
4.
Juan J. Muoz Cristina Roca Jos L. Santos Miguel Arroyo Rafael E. de Salamanca 《Basic & clinical pharmacology & toxicology》1993,73(4):189-191
Two alternatives for the treatment of lead intoxication, administration of zinc or a thiol donor, S-adenosyl-L-methionine (SAM), were analysed. Rats were exposed to lead (Pb)-acetate (60 mg/1) in drinking water during 90 days; one group also received SO4Zn in water (40 mg/l), while another received both Pb and SAM (5 mg/24 hr intraperitoneally. Erythrocytic δ-aminolaevulinic dehydratase (ALA-D) activity was significantly reduced (P<0.001) both in rats receiving Pb alone and in rats receiving Pb and each of the other two treatments. The high erythrocytic uroporphyrinogen synthetase (URO-S) activity noticed in Pb administered rats, was significantly (P< 0.001) reduced in animals treated either with zinc or with SAM. Hepatic ALA-D activity tended to decrease while renal enzyme activity was not modified by the low level Pb exposure used in this work. Interestingly, SAM treated rats in both tissues exhibited significantly (P<0.01) higher activities of the enzyme. It is argued that SAM treatment causes a surplus of thiols that allows the full expression of ALA-D catalytic activity. 相似文献
5.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
6.
7.
8.
9.
10.